Vitrafy Life Sciences Ltd. (VFY) Price & Analysis
VFY Stock Chart & Stats
A$2.27A$0.02(0.89%)
At close: 4:00 PM EDT
- Day’s Range
- AUD 2.16 - AUD 2.27
- 52-Week Range
- AUD 1.15 - AUD 4.66
- Previous Close
- AUD 2.25
- Volume
- 31.67K
- Average Volume (3M)
- 55.94K
- Market Cap
- AUD 173.08M
- Enterprise Value
- AUD 153.37M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 0.96
- Next Earnings
- Feb 11, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Vitrafy Life Sciences Ltd. News
VFY FAQ
What was Vitrafy Life Sciences Ltd.’s price range in the past 12 months?
Vitrafy Life Sciences Ltd. lowest share price was AU$1.15 and its highest was AU$4.66 in the past 12 months.
What is Vitrafy Life Sciences Ltd.’s market cap?
Vitrafy Life Sciences Ltd.’s market cap is AU$173.08M.
When is Vitrafy Life Sciences Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Vitrafy Life Sciences Ltd.’s earnings last quarter?
Vitrafy Life Sciences Ltd. released its earnings results on Aug 03, 2026. The company reported -AU$0.14 earnings per share for the quarter.
Is Vitrafy Life Sciences Ltd. overvalued?
According to Wall Street analysts Vitrafy Life Sciences Ltd.’s price is currently Undervalued.
Does Vitrafy Life Sciences Ltd. pay dividends?
Vitrafy Life Sciences Ltd. does not currently pay dividends.
What is Vitrafy Life Sciences Ltd.’s EPS estimate?
Vitrafy Life Sciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vitrafy Life Sciences Ltd. have?
Vitrafy Life Sciences Ltd. has 76,246,460 shares outstanding.
What happened to Vitrafy Life Sciences Ltd.’s price movement after its last earnings report?
Vitrafy Life Sciences Ltd. reported an EPS of -AU$0.14 in its last earnings report. Following the earnings report the stock price went down -0.27%.
Which hedge fund is a major shareholder of Vitrafy Life Sciences Ltd.?
Currently, no hedge funds are holding shares in AU:VFY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitrafy Life Sciences Ltd. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited has developed cryopreservation technology that dramatically improves cell survival rates across multiple applications including blood platelets, cell & gene therapies, aquaculture and bovine reproduction. The Company provides complete cryopreservation solutions through its managed service revenue model, utilising its FDA-registered Smart Freezing and Smart Thawing devices, integrated LifeChain software platform, and Smart Packaging systems. Vitrafy has designed and developed an innovative cryopreservation solution, which includes smart cryopreservation medical devices and packaging, and a sample quality management software platform known as LifeChain.
- Sector
- General
- Industry
- Medical - Specialties
- CEO
- Brenton Michael Leslie Owens
- Website
- www.vitrafy.com
- Address
- 385 Bourke Street Suite 2, Level 11, Melbourne, VIC, 3000, AU
Vitrafy Life Sciences Ltd. (VFY) Earnings & Revenues
VFY Stock 12 Month Forecast
Average Price Target
AUD 4.97▲(118.94% Upside)
Past 12 Months12 Month ForecastJan2026Oct2026
HighAUD 5.06
AverageAUD 4.97
LowAUD 4.85
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |